WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,15 ฿
arrow_downward
-0,96%(-0,050) 1 d
15 oct, 15:06:08 GMT+7 · THB
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de WUXI06...
Abrir
5,25 ฿
Alto
5,35 ฿
Bajo
5,15 ฿
Cap. burs.
200,24 mil M
Vol. medio
93,60 mil
Volumen
281,24 mil
Máximo en 52 sem.
6,25 ฿
Mínimo en 52 sem.
3,02 ฿
Acciones en circulación
4116,76 M
N.º de empleados
15 mil
Abrir
5,25 ฿
Alto
5,35 ฿
Bajo
5,15 ฿
Cap. burs.
200,24 mil M
Vol. medio
93,60 mil
Volumen
281,24 mil
Máximo en 52 sem.
6,25 ฿
Mínimo en 52 sem.
3,02 ฿
Acciones en circulación
4116,76 M
N.º de empleados
15 mil
Noticias
De fuentes web y partners de noticias
El Ecosistema Startup
·
hace 23 horas
S&P 500: IA impulsa 34% de crecimiento en ganancias
MarketScreener España
·
hace 4 horas
El S&P 500 retrocedió ligeramente tras el cierre de la Bolsa de Estocolmo el miércoles
Perfil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Acerca de Wuxi Biologics (Cayman) Inc. KKPS DR